These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20307571)

  • 1. Outcomes of cryptococcal meningitis in antiretroviral naïve and experienced patients in South Africa.
    Jarvis JN; Meintjes G; Harrison TS
    J Infect; 2010 Jun; 60(6):496-8. PubMed ID: 20307571
    [No Abstract]   [Full Text] [Related]  

  • 2. Cryptococcal Meningitis Presenting as a Complication in HIV-infected Children: A Case Series From Sub-Saharan Africa.
    Nyazika TK; Masanganise F; Hagen F; Bwakura-Dangarembizi MF; Ticklay IM; Robertson VJ
    Pediatr Infect Dis J; 2016 Sep; 35(9):979-80. PubMed ID: 27187754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced Human Immunodeficiency Virus Disease in Botswana Following Successful Antiretroviral Therapy Rollout: Incidence of and Temporal Trends in Cryptococcal Meningitis.
    Tenforde MW; Mokomane M; Leeme T; Patel RKK; Lekwape N; Ramodimoosi C; Dube B; Williams EA; Mokobela KO; Tawanana E; Pilatwe T; Hurt WJ; Mitchell H; Banda DL; Stone H; Molefi M; Mokgacha K; Phillips H; Mullan PC; Steenhoff AP; Mashalla Y; Mine M; Jarvis JN
    Clin Infect Dis; 2017 Sep; 65(5):779-786. PubMed ID: 28505328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptococcal meningitis in a tertiary hospital in Pretoria, mortality and risk factors - A retrospective cohort study.
    Hiesgen J; Schutte C; Olorunju S; Retief J
    Int J STD AIDS; 2017 Apr; 28(5):480-485. PubMed ID: 27255493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and duration.
    Alufandika M; Lawrence DS; Boyer-Chammard T; Kanyama C; Ndhlovu CE; Mosepele M; Tugume L; Meya D; Boulware DR; Rhein J; Muzoora C; Youssouf N; Molloy SF; Schutz C; Lortholary O; Meintjes G; Mwandumba HC; Harrison TS; Jarvis JN;
    AIDS; 2020 Jul; 34(9):1425-1428. PubMed ID: 32590438
    [No Abstract]   [Full Text] [Related]  

  • 6. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole.
    Bicanic T; Meintjes G; Wood R; Hayes M; Rebe K; Bekker LG; Harrison T
    Clin Infect Dis; 2007 Jul; 45(1):76-80. PubMed ID: 17554704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Cryptococcal Antigen Screening and Evolution of Asymptomatic Cryptococcal Antigenemia among HIV-Infected Women Starting Antiretroviral Therapy in Thailand.
    Kwan CK; Leelawiwat W; Intalapaporn P; Anekthananon T; Raengsakulrach B; Peters PJ; McNicholl JM; Park BJ; McConnell MS; Weidle PJ
    J Int Assoc Provid AIDS Care; 2014; 13(5):434-7. PubMed ID: 24003059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.
    Govender NP; Roy M; Mendes JF; Zulu TG; Chiller TM; Karstaedt AS
    HIV Med; 2015 Sep; 16(8):468-76. PubMed ID: 25689352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Asymptomatic Cryptococcal Antigenemia and Association with Follow-up Risk of Cryptococcal Meningitis and Mortality among HIV Infected Patients in North West India: A Prospective Cohort Study.
    Bhati R; Pramendra S; Sejoo B; Kumar D; Bohra GK; Meena DS; Verma D; Midha NK
    Curr HIV Res; 2021; 19(1):35-39. PubMed ID: 32860359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up and survival of antiretroviral-naive patients with cryptococcal meningitis in the pre-antiretroviral therapy era, Gauteng Province, South Africa.
    Park BJ; Shetty S; Ahlquist A; Greenbaum A; Miller JL; Motsi A; McCarthy K; Govender N;
    Int J STD AIDS; 2011 Apr; 22(4):199-203. PubMed ID: 21515751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing deaths from cryptococcal meningitis: from bench to bedside.
    Roy M; Chiller T
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):715-7. PubMed ID: 21905781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm
    Wykowski J; Galagan SR; Govere S; Wallis CL; Moosa MY; Celum C; Drain PK
    BMC Infect Dis; 2020 Jan; 20(1):61. PubMed ID: 31959112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation and Operational Research: Evaluation of a Public-Sector, Provider-Initiated Cryptococcal Antigen Screening and Treatment Program, Western Cape, South Africa.
    Vallabhaneni S; Longley N; Smith M; Smith R; Osler M; Kelly N; Cross A; Boulle A; Meintjes G; Govender NP
    J Acquir Immune Defic Syndr; 2016 Jun; 72(2):e37-e42. PubMed ID: 26926942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral roll-out, antifungal roll-back: access to treatment for cryptococcal meningitis.
    Bicanic T; Wood R; Bekker LG; Darder M; Meintjes G; Harrison TS
    Lancet Infect Dis; 2005 Sep; 5(9):530-1. PubMed ID: 16122672
    [No Abstract]   [Full Text] [Related]  

  • 15. Decreasing incidence of cryptococcal meningitis in West Africa in the era of highly active antiretroviral therapy.
    Bamba S; Lortholary O; Sawadogo A; Millogo A; Guiguemdé RT; Bretagne S
    AIDS; 2012 May; 26(8):1039-41. PubMed ID: 22552479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptococcal meningitis in HIV-infected patients: a longitudinal study in Cambodia.
    Espié E; Pinoges L; Balkan S; Chanchhaya N; Molfino L; Narom P; Pujades-Rodríguez M
    Trop Med Int Health; 2010 Nov; 15(11):1375-81. PubMed ID: 20868415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
    Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
    Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing but not treating: missed opportunities and lost lives in the South African antiretroviral therapy programme.
    Jarvis JN; Meintjes G; Wood R; Harrison TS
    AIDS; 2010 May; 24(8):1233-5. PubMed ID: 20421745
    [No Abstract]   [Full Text] [Related]  

  • 19. Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts--time to implement in South Africa?
    Jarvis JN; Harrison TS; Govender N; Lawn SD; Longley N; Bicanic T; Maartens G; Venter F; Bekker LG; Wood R; Meintjes G
    S Afr Med J; 2011 Apr; 101(4):232-4. PubMed ID: 21786721
    [No Abstract]   [Full Text] [Related]  

  • 20. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.
    Boulware DR; Meya DB; Muzoora C; Rolfes MA; Huppler Hullsiek K; Musubire A; Taseera K; Nabeta HW; Schutz C; Williams DA; Rajasingham R; Rhein J; Thienemann F; Lo MW; Nielsen K; Bergemann TL; Kambugu A; Manabe YC; Janoff EN; Bohjanen PR; Meintjes G;
    N Engl J Med; 2014 Jun; 370(26):2487-98. PubMed ID: 24963568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.